Spindola, Leticia M.
Santoro, Marcos L.
Pan, Pedro M.
Ota, Vanessa K.
Xavier, Gabriela
Carvalho, Carolina M.
Talarico, Fernanda
Sleiman, Patrick
March, Michael
Pellegrino, Renata
Brietzke, Elisa
Grassi-Oliveira, Rodrigo
Mari, Jair J.
Gadelha, Ary
Miguel, Euripedes C.
Rohde, Luis A.
Bressan, Rodrigo A.
Mazzotti, Diego R.
Sato, João R.
Salum, Giovanni A.
Hakonarson, Hakon
Belangero, Sintia I. http://orcid.org/0000-0002-2419-4351
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2014/07280-1, 2016/04983-7)
Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/05339-7)
Article History
Received: 15 January 2019
Accepted: 8 September 2019
First Online: 21 October 2019
Ethics approval and consent to participate
: The study was approved by the National Commission for Research Ethics (CONEP–Comissão Nacional de Ética em Pesquisa–CAAE: 74563817.7.1001.5327) and the Ethics Committees from UFRGS, UNIFESP, and FMUSP. The Research Ethics Committee approved the research protocol. All parents and children/youth provided written informed consent before inclusion in this cohort.
: Not applicable.
: PMP received a Post-Doctoral Scholarship from CAPES (Finance Code 001). LAR has received grant or research support from, served as a consultant to, and served on the speakers’ bureau of Eli Lilly and Co., Janssen, Medice, Novartis, and Shire. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by LAR have received unrestricted educational and research support from the following pharmaceutical companies: Eli Lilly and Co., Janssen, and Novartis. LAR has received authorship royalties from Oxford Press and ArtMed and travel grants from Shire to take part in the 2018 APA annual meeting and from Novartis to take part of the 2016 AACAP annual meeting. The other authors declare that they have no competing interests.